Lantern Pharma
LTRN
LTRN
30 hedge funds and large institutions have $4.95M invested in Lantern Pharma in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 13 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
54% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 13
Holders
30
Holding in Top 10
–
Calls
$10K
Puts
$2K
Top Buyers
| 1 | +$153K | |
| 2 | +$41.7K | |
| 3 | +$20.1K | |
| 4 |
CM
CM Management
Gulf Breeze,
Florida
|
+$17.6K |
| 5 |
MWM
Meridian Wealth Management
Lexington,
Kentucky
|
+$10.6K |
Top Sellers
| 1 | -$123K | |
| 2 | -$22K | |
| 3 | -$20.6K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$20.4K |
| 5 |
PFA
Pathway Financial Advisors
South Burlington,
Vermont
|
-$15.1K |